NCT05453409

Study on Clinical Features, Treatment Mode and Survival of Sarcoma

A Single-center Retrospective Study of Clinical Features, Treatment Patterns, and Survival of Sarcomas

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 6,000 (estimated)
• Sponsor: Henan Cancer Hospital · Other Government
• Sex: All
• Age: 6 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The clinical data of all eligible patients who received chemotherapy, radiotherapy, targeted therapy, immunotherapy, interventional therapy and surgery in Henan Tumor Hospital from June 1, 2012 to May 30, 2022 were retrospectively collected.

Detailed description

This study was a single-center retrospective clinical study, which retrospectively collected the clinical data of all eligible patients receiving chemotherapy, radiotherapy, targeted therapy, immunotherapy, interventional therapy and surgical treatment in Henan Tumor Hospital from June 1, 2012 to May 30, 2022. The efficacy, recurrence and survival of various treatments were collected.

Conditions

• Sarcoma

Interventions

Type	Name	Description
OTHER	No intervention	No intervention

Timeline

• Start date: 2022-06-07
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2022-07-12
• Last updated: 2024-02-07

Locations

1 site across 1 country: China